The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps

被引:10
|
作者
Wong, Anabelle [1 ,2 ]
Guevara, Laura Andrea Barrero [1 ,2 ]
Goult, Elizabeth [1 ]
Briga, Michael [1 ]
Kramer, Sarah C. [1 ]
Kovacevic, Aleksandra [3 ,4 ]
Opatowski, Lulla [3 ,4 ]
de Celles, Matthieu Domenech [1 ]
机构
[1] Max Planck Inst Infect Biol, Infect Dis Epidemiol Grp, Berlin, Germany
[2] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany
[3] Univ Paris Cite, Inst Pasteur, Epidemiol & Modelling Antibiot Evas, Paris, France
[4] Univ Versailles St Quentin En Yvelines, Univ Paris Saclay, Antiinfect Evas & Pharmacoepidemiol Team, CESP,INSERM,U1018, Montigny Le Bretonneux, France
关键词
SYNDROME CORONAVIRUS 2; INFLUENZA-A VIRUS; STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-INFECTION; COVID-19; COINFECTION; DISEASE; IMPACT; RISK; VACCINATION;
D O I
10.1371/journal.ppat.1011167
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Despite the availability of effective vaccines, the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggests that cocirculation with other pathogens and resulting multiepidemics (of, for example, COVID-19 and influenza) may become increasingly frequent. To better forecast and control the risk of such multiepidemics, it is essential to elucidate the potential interactions of SARS-CoV-2 with other pathogens; these interactions, however, remain poorly defined. Here, we aimed to review the current body of evidence about SARS-CoV-2 interactions. Our review is structured in four parts. To study pathogen interactions in a systematic and comprehensive way, we first developed a general framework to capture their major components: sign (either negative for antagonistic interactions or positive for synergistic interactions), strength (i.e., magnitude of the interaction), symmetry (describing whether the interaction depends on the order of infection of interacting pathogens), duration (describing whether the interaction is short-lived or long-lived), and mechanism (e.g., whether interaction modifies susceptibility to infection, transmissibility of infection, or severity of disease). Second, we reviewed the experimental evidence from animal models about SARS-CoV-2 interactions. Of the 14 studies identified, 11 focused on the outcomes of coinfection with nonattenuated influenza A viruses (IAVs), and 3 with other pathogens. The 11 studies on IAV used different designs and animal models (ferrets, hamsters, and mice) but generally demonstrated that coinfection increased disease severity compared with either monoinfection. By contrast, the effect of coinfection on the viral load of either virus was variable and inconsistent across studies. Third, we reviewed the epidemiological evidence about SARS-CoV-2 interactions in human populations. Although numerous studies were identified, only a few were specifically designed to infer interaction, and many were prone to multiple biases, including confounding. Nevertheless, their results suggested that influenza and pneumococcal conjugate vaccinations were associated with a reduced risk of SARS-CoV-2 infection. Finally, fourth, we formulated simple transmission models of SARS-CoV-2 cocirculation with an epidemic viral pathogen or an endemic bacterial pathogen, showing how they can naturally incorporate the proposed framework. More generally, we argue that such models, when designed with an integrative and multidisciplinary perspective, will be invaluable tools to resolve the substantial uncertainties that remain about SARS-CoV-2 interactions.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Air travel and SARS-CoV-2: many remaining knowledge gaps
    Freedman, David O.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2022, 29 (08)
  • [2] An epidemiological model for SARS-CoV-2
    Monteiro, L. H. A.
    [J]. ECOLOGICAL COMPLEXITY, 2020, 43
  • [3] SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
    Datta, Prasun K.
    Liu, Fengming
    Fischer, Tracy
    Rappaport, Jay
    Qin, Xuebin
    [J]. THERANOSTICS, 2020, 10 (16): : 7448 - 7464
  • [4] Epidemiological assessment of SARS-CoV-2 reinfection
    Almadhi, Marwa
    Alsayyad, Adel Salman
    Conroy, Ronan
    Atkin, Stephen
    Al Awadhi, Abdulla
    Al-Tawfiq, Jaffar A.
    AlQahtani, Manaf
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 9 - 16
  • [5] Modelling the epidemiological implications for SARS-CoV-2 of Christmas household bubbles in England
    Hill, Edward M.
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 2023, 557
  • [6] Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications
    Mohammed Al-Beltagi
    Nermin Kamal Saeed
    Adel Salah Bediwy
    Yasser El-Sawaf
    [J]. World Journal of Gastroenterology, 2021, 27 (16) : 1716 - 1727
  • [7] Paediatric gastrointestinal disorders in SARS-CoV-2 infection: Epidemiological and clinical implications
    Al-Beltagi, Mohammed
    Saeed, Nermin Kamal
    Bediwy, Adel Salah
    El-Sawaf, Yasser
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (16) : 1716 - 1727
  • [8] Assessing the current epidemiological status of SARS-CoV-2 and its potential evolution
    Nicola Abrescia
    Maurizio D’Abbraccio
    Mario De Marco
    Adelaide Maddaloni
    [J]. Infection, 2024, 52 : 699 - 700
  • [9] Assessing the current epidemiological status of SARS-CoV-2 and its potential evolution
    Abrescia, Nicola
    D'Abbraccio, Maurizio
    De Marco, Mario
    Maddaloni, Adelaide
    [J]. INFECTION, 2024, 52 (02) : 699 - 700
  • [10] Immune response to SARS-CoV-2 in children: A review of the current knowledge
    Filippatos Filippos
    Tatsi Elizabeth-Barbara
    Michos Athanasios
    [J]. 儿科学研究(英文), 2021, 05 (03) : 217 - 228